MEDICINE & HEALTHNow with more than three million deaths worldwide, the COVID-19 origin remains uncertain. For more than a year now, this pandemic has disrupted lives anywhere in the world.
The Valneva COVID-19 vaccine is said to be reliant against the virus. This shot from the French company, Valneva, has yet to reach completion of his clinical trials.
Scientists warn that a year of virtually no flu could mean that more people are susceptible in the next season. Vaccines will still be key in preventing infection.
COVID-19 can spread to people more than six feet apart and, in some circumstances, to those who have passed through a space where the infection is still lingering.
Several factors characteristic of modern human lifestyle are reportedly responsible for the "perfect storm" that fosters the growth and transmission of diseases like COVID-19, a new study suggests.
Scientists in the Netherlands have trained bees so they can identify COVID-19 using their sense of smell, a Wageningen University press release specified.
Mesa County's health leaders recently reported cases of COVID-19 continue to rise among Coloradan children, and a new Variant inflicting havoc in India is presently making its way around Colorado.
An early clinical trial recently showed that the new Moderna COVID-19 booster could be an effective shield against the variants of coronavirus originally found in South Africa and Brazil.
Pfizer-BioNTech's Comirnaty COVID-19 vaccine, according to reports, has one big weakness and that's the Moderna COVID-19 Vaccine, mRNA-1273, specifically its less cooling requirement.
New research recently found that people who are considered to be in the upper portions of the 'healthy' body mass index or BMI range are at higher risk of contracting severe COVID-19.
Since COVID-19 started its worldwide transmission, cases of influenza viruses reported to the World Health Organization have plummeted to minuscule levels.
New research recently found populations with shift work or those working on irregular hours are substantially more possible to become infected by COVID-19 than those who follow more traditional schedules at work.
Experts discuss the rare cases of blood clots linked to the COVID-19 Johnson & Johnson vaccine. The US Centers for Disease Control and Prevention proposed a two-week delay in the use of the Johnson & Johnson (J&J) COVID-19 vaccine earlier this month, following news that six women developed blot clots, and one of them died within two weeks of receiving it.
Hawaii's Department of Health reported the first pediatric COVID-19 death of the state. It is a boy with underlying conditions who traveled with his vaccinated parents to Hawaii.
Pfizer's COVID-19 antiviral drug may be available by the end of this year. The drug may stop COVID-19 from reproducing in the patient's nose, throat, and lungs.